Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
Saved in:
| Title: | Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. |
|---|---|
| Authors: | Hong HS; CureVac AG , Tübingen, Germany., Koch SD; CureVac AG , Tübingen, Germany., Scheel B; CureVac AG , Tübingen, Germany., Gnad-Vogt U; CureVac AG , Tübingen, Germany., Schröder A; CureVac AG , Tübingen, Germany., Kallen KJ; CureVac AG , Tübingen, Germany., Wiegand V; CureVac AG , Tübingen, Germany., Backert L; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen , Germany., Kohlbacher O; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen, Germany; Quantitative Biology Center, University of Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany., Hoerr I; CureVac AG , Tübingen, Germany., Fotin-Mleczek M; CureVac AG , Tübingen, Germany., Billingsley JM; Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough , MA, USA. |
| Source: | Oncoimmunology [Oncoimmunology] 2016 Nov 18; Vol. 5 (12), pp. e1249560. Date of Electronic Publication: 2016 Nov 18 (Print Publication: 2016). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28123889 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hong+HS%22">Hong HS</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Koch+SD%22">Koch SD</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scheel+B%22">Scheel B</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gnad-Vogt+U%22">Gnad-Vogt U</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schröder+A%22">Schröder A</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kallen+KJ%22">Kallen KJ</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wiegand+V%22">Wiegand V</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Backert+L%22">Backert L</searchLink>; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen , Germany.<br /><searchLink fieldCode="AU" term="%22Kohlbacher+O%22">Kohlbacher O</searchLink>; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen, Germany; Quantitative Biology Center, University of Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hoerr+I%22">Hoerr I</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Fotin-Mleczek+M%22">Fotin-Mleczek M</searchLink>; CureVac AG , Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Billingsley+JM%22">Billingsley JM</searchLink>; Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough , MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2016 Nov 18; Vol. 5 (12), pp. e1249560. <i>Date of Electronic Publication: </i>2016 Nov 18 (<i>Print Publication: </i>2016). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28123889 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2016.1249560 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1249560 Titles: – TitleFull: Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hong HS – PersonEntity: Name: NameFull: Koch SD – PersonEntity: Name: NameFull: Scheel B – PersonEntity: Name: NameFull: Gnad-Vogt U – PersonEntity: Name: NameFull: Schröder A – PersonEntity: Name: NameFull: Kallen KJ – PersonEntity: Name: NameFull: Wiegand V – PersonEntity: Name: NameFull: Backert L – PersonEntity: Name: NameFull: Kohlbacher O – PersonEntity: Name: NameFull: Hoerr I – PersonEntity: Name: NameFull: Fotin-Mleczek M – PersonEntity: Name: NameFull: Billingsley JM IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 11 Text: 2016 Nov 18 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 5 – Type: issue Value: 12 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |
